A new study details an efficient and scalable method to generate human inner ear hair-like cells in the lab, potentially offering a new tool for hearing loss research.

AAVantgarde is now initiating ‘CELESTE’, a first-in-human Phase 1/2 clinical trial in the United States, to evaluate the safety, tolerability, and initial efficacy of AAVB-039 in patients with ...